Occlusion Balloon vs. Ureteral Catheter for Kidney Stones
Trial Summary
What is the purpose of this trial?
Occlusion Balloon catheter provides the ability to occlude the exit of the kidney pelvis during percutaneous nephrolithotomy (PCNL) and potentially prevents the migration of stone fragments into the ureter. The necessity for it might be questioned during supine PCNL due to the upward oblique position of the kidney. The objective of the study is to compare the presence of ureteral stone fragments upon completion of supine PCNL with and without using an occlusion balloon catheter (OBC).
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of this treatment for kidney stones?
Is the use of occlusion balloon catheters and ureteral catheters generally safe for humans?
How does the occlusion balloon catheter treatment for kidney stones differ from other treatments?
Research Team
Mantu Gupta, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Eligibility Criteria
Adults over 18 with kidney stones who are scheduled for a type of surgery called PCNL can join. They must be able to consent. Those with urinary tract anomalies, previous related surgeries, or pregnant women cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo percutaneous nephrolithotomy (PCNL) with either an occlusion balloon catheter or a 5FR ureteral catheter
Follow-up
Participants are monitored for the presence of ureteral stone fragments and procedural outcomes
Treatment Details
Interventions
- 5FR Ureteral Catheter
- Occlusion Balloon Catheter
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor